New Delhi, Dec 29 (IANS) Sepsis, a severe and often fatal complication of infection, is a leading cause of both acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Now, researchers report medical ozone therapy as a promising new treatment for sepsis-induced ALI.
This innovative approach could significantly improve survival rates and lung function in preclinical models, offering hope for patients with limited treatment options, according to the study from Nanjing Medical University in China.
Neutrophil extracellular traps (NETs) play a central role in the progression of sepsis, as they are involved in trapping pathogens but can also trigger excessive inflammation, exacerbating lung injury.
The complexity of sepsis-induced ALI, driven by the interplay among inflammation, immune dysregulation, and coagulation, calls for innovative therapeutic strategies to better manage this critical condition.
The study, published in the Journal of Biomedical Research, detailed how medical ozone therapy effectively clear NETs, significantly improving survival rates and lung function in mice suffering from sepsis-induced ALI.
This work represents a critical step forward in the search for new treatments for this deadly condition. The study provides an in-depth examination of the mechanisms behind ozone therapy’s therapeutic effects on sepsis-induced ALI.
“Our research demonstrates that medical ozone therapy could dramatically improve the management of sepsis-induced ALI. This represents a promising new approach to critical care that could lead to better outcomes for patients suffering from sepsis,” said Dr. Wen-Tao Liu, the principal investigator of the study.
The implications of this study are far-reaching. If subsequent research confirms these results in human trials, medical ozone therapy could become a viable and effective treatment for sepsis-induced lung injury, a condition currently with few treatment options.
Ozone therapy’s potential to improve survival and lung function could transform the management of sepsis, offering new hope for patients who face a bleak prognosis.
The study authors noted that as this promising therapy advances through further research, it may become a cornerstone in the fight against sepsis, reshaping how we treat this life-threatening condition.
—IANS
na/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
